Nifedipine vs. Ritodrine for Arresting Preterm Labor The beta-receptor agonist ritodrine is commonly used to arrest premature labor. However, its use is associated with significant side effects, including nausea, vomiting, palpitations and chest pain.
Effects of Estrogen Therapy on Postmenopausal Lipid Levels Heart disease is the cause of death in more than 36 percent of menopausal and postmenopausal women. Several studies have shown that hormone replacement therapy substantially reduces (up to 70 p
Coronary Disease Mortality and Changes in Risk Factors A dramatic reduction in cardiovascular disease mortality during the past 30 years has been well documented. To better understand the reasons behind this decline, Sytkowski and colleagues compared t
Chlamydial Infection and Pregnancy Outcome Cervical infection with Chlamydia trachomatis has become widespread. Certain groups of pregnant women are at increased risk of chlamydial infection. These include women under age 20, single women, women, of l
24-Hour Monitoring of Blood Pressure Up to 30 percent of patients with elevated blood pressure in the physician's office may have normal readings in other settings. Long-term follow-up evaluations confirm that end-organ damage is more closely correlate
Estrogen Prophylaxis Burden of Suffering An estimated 1.3 million osteoporosis-related fractures occur each year in the United States. [1] Most of these injuries occur in postmenopausal women. It has been estimated that about one-qu
Viral Encephalitis Approximately 20,000 cases of encephalitis occur annually in the United States. Whitley reviews the diagnosis and treatment of acute and postinfectious encephalitis. Clinical findings commonly seen in patients with acute vir
International Differences in Obstetric Interventions Notzon conducted a study to compare the worldwide rates of cesarean section, vaginal birth after cesarean section and operative delivery (forceps and vacuum extraction) during the years 1975 through 1
AFP's series of excerpts from the 1989 report of the U. S. Preventive Services Task Force (1) concludes this month with the publication of "Postexposure Prophylaxis." (2) Since the Prevention in Clinical Practice" series began in june 1989, AFP has p
In this issue, Dr. Pichichero presents an excellent overview of the treatment of streptococcal pharyngitis. (1) He outlines what may be the emergence of new therapeutic issues in streptococcal pharyngitis--primarily, increased failure rates in eradica
Author: Monica Preboth
Date: August 15, 2000
The Anxiety Disorders Association of America (ADAA) and the National Institute of Mental Health (NIMH) have published a new monograph on the treatment of anxiety disorders in children and adolescents. "Conference on Treating Anxiety Disorders in Youth: Current Problems and Future Solutions" was the result of a working conference held in October 1998 that was cosponsored by the ADAA and NIMH.
The monograph highlights the following areas for future research: improve diagnostic categories to better capture the clinical picture of anxiety disorders in children; expand the number and type of study designs for research on behavioral and pharmacologic treatments; refine measures of effectiveness of treatment to include behavioral observation, laboratory and performance-based measures; and conduct research on risk factors (such as family history, child's temperament, parenting behavior, and academic or social failure experiences) and on the existence and role of protective factors.
The text of the monograph is posted on the ADAA Web site at http://www.adaa.org. For more information, contact the ADAA by mail at 11900 Parklawn Dr., Ste. 100, Rockville, MD 20852-2624 or by calling 301-231-9350.
COPYRIGHT 2000 American Academy of Family PhysiciansCOPYRIGHT 2000 Gale Group